BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 1587757)

  • 1. Enhancement of tumor radiosensitivity and reduced hypoxia-dependent binding of a 2-nitroimidazole with normobaric oxygen and carbogen: a therapeutic comparison with skin and kidneys.
    Rojas A; Joiner MC; Hodgkiss RJ; Carl U; Kjellen E; Wilson GD
    Int J Radiat Oncol Biol Phys; 1992; 23(2):361-6. PubMed ID: 1587757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the radiation response in a C3H mouse mammary carcinoma by normobaric oxygen or carbogen breathing.
    Grau C; Horsman MR; Overgaard J
    Int J Radiat Oncol Biol Phys; 1992; 22(3):415-9. PubMed ID: 1735671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiosensitisation in normal tissues with oxygen, carbogen or nicotinamide: therapeutic gain comparisons for fractionated x-ray schedules.
    Rojas A; Vojnovic B; Johns H; Joiner MC; Martindale C; Fowler JF; Denekamp J
    Radiother Oncol; 1996 Apr; 39(1):53-64. PubMed ID: 8735494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Fluosol DA 20% and carbogen on the radioresponse of SCK tumors and skin of A/J mice.
    Lee I; Levitt SH; Song CW
    Radiat Res; 1987 Oct; 112(1):173-82. PubMed ID: 3116597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of normobaric oxygen on tumor radiosensitivity: fractionated studies.
    Rojas A; Carl U; Reghebi K
    Int J Radiat Oncol Biol Phys; 1990 Mar; 18(3):547-53. PubMed ID: 2108105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiosensitization of murine tumors by Fluosol-DA 20%.
    Lee I; Levitt SH; Song CW
    Radiat Res; 1990 Jun; 122(3):275-9. PubMed ID: 2113298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbogen and nicotinamide as radiosensitizers in a murine mammary carcinoma using conventional and accelerated radiotherapy.
    Rojas A; Hirst VK; Calvert AS; Johns H
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):357-65. PubMed ID: 8567336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.
    Chaplin DJ; Horsman MR; Siemann DW
    Br J Cancer; 1993 Aug; 68(2):269-73. PubMed ID: 8347481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The radiation response of KHT sarcomas following nicotinamide treatment and carbogen breathing.
    Siemann DW; Horsman MR; Chaplin DJ
    Radiother Oncol; 1994 May; 31(2):117-22. PubMed ID: 8066190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.
    Horsman MR; Overgaard J
    Radiother Oncol; 2004 Mar; 70(3):301-9. PubMed ID: 15064017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactions of tumors and normal tissues in mice to irradiation in the presence and absence of a perfluorochemical emulsion.
    Rockwell S; Mate TP; Irvin CG; Nierenburg M
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1315-8. PubMed ID: 3093416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractionated irradiation combined with carbogen breathing and nicotinamide of two human glioblastomas grafted in nude mice.
    Sun LQ; Coucke PA; Mirimanoff RO; Buchegger F
    Radiat Res; 2001 Jan; 155(1 Pt 1):26-31. PubMed ID: 11121212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiosensitizing effect of nicotinamide and carbogen combined in fractionated pions or x-rays in SCCVII tumors.
    Ohizumi Y; Lam GK; Pickles T; Fryer C; Chaplin DJ
    Radiat Med; 1995; 13(6):291-5. PubMed ID: 8850370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments.
    Kjellen E; Joiner MC; Collier JM; Johns H; Rojas A
    Radiother Oncol; 1991 Oct; 22(2):81-91. PubMed ID: 1835542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing.
    Horsman MR; Nordsmark M; Khalil AA; Hill SA; Chaplin DJ; Siemann DW; Overgaard J
    Acta Oncol; 1994; 33(4):371-6. PubMed ID: 8018368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The optimal combination of hyperthermia and carbogen breathing to increase tumor oxygenation and radiation response.
    Griffin RJ; Okajima K; Song CW
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):865-9. PubMed ID: 9845112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is sensitization with nicotinamide and carbogen dependent on nicotinamide concentration at the time of irradiation?
    Rojas A; Stratford MR; Bentzen SM; Denekamp J
    Int J Radiat Biol; 2004 Jul; 80(7):499-506. PubMed ID: 15360088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should carbogen and nicotinamide be given throughout the full course of fractionated radiotherapy regimens?
    Rojas AM; Johns H; Fiat PR
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1101-5. PubMed ID: 8262834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of radiosensitivity of rat rhabdomyosarcoma R1H with normobaric carbogen and hyperbaric oxygen (HBO) using conventionally fractionated irradiation.
    Hartmann KA; Carl UM; Plugge DC; Schneider CJ; Sminia P
    Br J Radiol; 1998 Apr; 71(844):433-7. PubMed ID: 9659137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of carbogen on tumour oxygenation and 32P-colloid interstitial irradiation response.
    Zhan HW; Liu HB; Bao CK; Ye XJ; Zhang H; He GQ
    Med Sci Monit; 2010 Jan; 16(1):BR11-6. PubMed ID: 20037480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.